These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
497 related articles for article (PubMed ID: 33567779)
1. Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker. Piao XM; Cha EJ; Yun SJ; Kim WJ Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567779 [TBL] [Abstract][Full Text] [Related]
2. Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer. Wang J; Ni J; Beretov J; Thompson J; Graham P; Li Y Crit Rev Oncol Hematol; 2020 Jan; 145():102860. PubMed ID: 31874447 [TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy: Exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer. Preethi KA; Selvakumar SC; Ross K; Jayaraman S; Tusubira D; Sekar D Mol Cancer; 2022 Feb; 21(1):54. PubMed ID: 35172817 [TBL] [Abstract][Full Text] [Related]
4. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer. Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319 [TBL] [Abstract][Full Text] [Related]
5. Exosomal Non Coding RNA in LIQUID Biopsies as a Promising Biomarker for Colorectal Cancer. Baassiri A; Nassar F; Mukherji D; Shamseddine A; Nasr R; Temraz S Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092975 [TBL] [Abstract][Full Text] [Related]
6. Cell-Free DNA, MicroRNAs, Proteins, and Peptides as Liquid Biopsy Biomarkers in Prostate Cancer and Bladder Cancer. Chen H; Xu C; Fang Z; Mao S Methods Mol Biol; 2023; 2695():165-179. PubMed ID: 37450118 [TBL] [Abstract][Full Text] [Related]
7. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities. Salehi M; Sharifi M J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722 [TBL] [Abstract][Full Text] [Related]
8. Bladder cancer: non-coding RNAs and exosomal non-coding RNAs. Zhao J; Ma Y; Zheng X; Sun Z; Lin H; Du C; Cao J Funct Integr Genomics; 2024 Aug; 24(5):147. PubMed ID: 39217254 [TBL] [Abstract][Full Text] [Related]
9. Emerging role of exosomes as biomarkers in cancer treatment and diagnosis. Hanjani NA; Esmaelizad N; Zanganeh S; Gharavi AT; Heidarizadeh P; Radfar M; Omidi F; MacLoughlin R; Doroudian M Crit Rev Oncol Hematol; 2022 Jan; 169():103565. PubMed ID: 34871719 [TBL] [Abstract][Full Text] [Related]
10. Urinary exosomal shuttle RNA: Promising cancer diagnosis biomarkers of lower urinary tract. De Palma G; Di Lorenzo VF; Krol S; Paradiso AV Int J Biol Markers; 2019 Jun; 34(2):101-107. PubMed ID: 30862241 [TBL] [Abstract][Full Text] [Related]
11. A Non-invasive Liquid Biopsy Screening of Urine-Derived Exosomes for miRNAs as Biomarkers in Endometrial Cancer Patients. Srivastava A; Moxley K; Ruskin R; Dhanasekaran DN; Zhao YD; Ramesh R AAPS J; 2018 Jul; 20(5):82. PubMed ID: 29987691 [TBL] [Abstract][Full Text] [Related]
12. Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring. Lodewijk I; Dueñas M; Rubio C; Munera-Maravilla E; Segovia C; Bernardini A; Teijeira A; Paramio JM; Suárez-Cabrera C Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149597 [TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy in bladder cancer: State of the art and future perspectives. Crocetto F; Barone B; Ferro M; Busetto GM; La Civita E; Buonerba C; Di Lorenzo G; Terracciano D; Schalken JA Crit Rev Oncol Hematol; 2022 Feb; 170():103577. PubMed ID: 34999017 [TBL] [Abstract][Full Text] [Related]
14. Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer. Juracek J; Peltanova B; Dolezel J; Fedorko M; Pacik D; Radova L; Vesela P; Svoboda M; Slaby O; Stanik M J Cell Mol Med; 2018 Mar; 22(3):2033-2038. PubMed ID: 29363887 [TBL] [Abstract][Full Text] [Related]
15. ExomiRs: A Novel Strategy in Cancer Diagnosis and Therapy. Gorji-Bahri G; Hashemi A; Moghimi HR Curr Gene Ther; 2018; 18(6):336-350. PubMed ID: 30332956 [TBL] [Abstract][Full Text] [Related]
16. Exosomal microRNAs (exomiRs): Small molecules with a big role in cancer. Bhome R; Del Vecchio F; Lee GH; Bullock MD; Primrose JN; Sayan AE; Mirnezami AH Cancer Lett; 2018 Apr; 420():228-235. PubMed ID: 29425686 [TBL] [Abstract][Full Text] [Related]
17. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy. Rodríguez-Martínez A; de Miguel-Pérez D; Ortega FG; García-Puche JL; Robles-Fernández I; Exposito J; Martorell-Marugan J; Carmona-Sáez P; Garrido-Navas MDC; Rolfo C; Ilyine H; Lorente JA; Legueren M; Serrano MJ Breast Cancer Res; 2019 Feb; 21(1):21. PubMed ID: 30728048 [TBL] [Abstract][Full Text] [Related]
18. Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Bladder Cancer Diagnosis and Prognosis. Wang J; Yang K; Yuan W; Gao Z Med Sci Monit; 2018 Dec; 24():9307-9316. PubMed ID: 30576305 [TBL] [Abstract][Full Text] [Related]
19. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression. Zheng R; Du M; Wang X; Xu W; Liang J; Wang W; Lv Q; Qin C; Chu H; Wang M; Yuan L; Qian J; Zhang Z Mol Cancer; 2018 Oct; 17(1):143. PubMed ID: 30285771 [TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Exosomal miRNA Biosensing for Liquid Biopsy. Lin B; Jiang J; Jia J; Zhou X Molecules; 2022 Oct; 27(21):. PubMed ID: 36363975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]